文献速递头颈外科咽喉与嗓音

头颈癌幸存者吞咽困难及相关结局的两年患病率:基于SEER-Medicare数据库的更新分析

Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
PubMed 文献 · Head Neck · 2018-12-07

基于SEER-Medicare数据库分析16194例头颈癌患者(2002-2011年),估算两年吞咽困难患病率为45.3%(95%CI:44.5-46.1),狭窄为10.2%,肺炎为26.3%,吸入性肺炎为8.6%;吞咽困难在10年间增加11.7%(P<.001),放化疗和 multimodality 治疗后患病率最高。作者结论认为该患病率与采用类似方法的前十年(1992-1999年)报道率相似。

要点

  • 头颈癌幸存者两年吞咽困难患病率为45.3%(95%CI:44.5-46.1)。
  • 吞咽困难患病率在10年间增加11.7%(P<.001)。
  • 放化疗和多模式治疗后吞咽困难患病率最高。

核心结论

  • 与采用类似方法的前十年(1992-1999年)已发表率相比,本研究2002-2011年基于理赔数据的吞咽困难患病率相似。
  • 这些结果提示吞咽困难作为一种高患病率并发症持续存在,即使在高度适形放疗和微创手术普及的十年中也是如此。

研究设计与样本

  • 分析监测、流行病学和最终结果(SEER)-Medicare理赔数据,纳入16194例头颈癌患者(2002-2011年),估算两年吞咽困难、狭窄和吸入性肺炎的患病率,并得出治疗和部位特异性估计。

主要发现

  • 吞咽困难患病率为45.3%(95%CI:44.5-46.1),狭窄为10.2%(95%CI:9.7-10.7),肺炎为26.3%(95%CI:25.6-26.9),吸入性肺炎为8.6%(95%CI:8.2-9.1)。
  • 吞咽困难在10年间增加11.7%(P<.001)。
  • 放化疗和多模式治疗后患病率最高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the study was to examine prevalence of dysphagia at the population level in head and neck cancer (HNC) survivors. METHODS: Surveillance, Epidemiology, and End Results-Medicare claims among 16 194 patients with HNC (2002-2011) were analyzed to estimate 2-year prevalence of dysphagia, stricture, and aspiration pneumonia, and derive treatment- and site-specific estimates. RESULTS: Prevalence of dysphagia, stricture, pneumonia, and aspiration pneumonia was 45.3% (95% confidence interval [CI]: 44.5-46.1), 10.2% (95% CI: 9.7-10.7), 26.3% (95% CI: 25.6-26.9), and 8.6% (95% CI: 8.2-9.1), respectively. Dysphagia increased by 11.7% over the 10-year period (P < .001). Prevalence was highest after chemoradiation and multimodality therapy. CONCLUSION: Comparing to published rates using similar methodology the preceding decade (1992-1999), prevalence of dysphagia based on claims data was similar in 2002-2011 in this study. These results suggest persistence of dysphagia as a highly prevalent morbidity, even in the decade in which highly conformal radiotherapy and minimally invasive surgeries were popularized.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Hutcheson KA, Nurgalieva Z, Zhao H, et al. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck. 2018. PMID: 30536748. doi:10.1002/hed.25412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。